Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPA3 | P15088 | 2/20 | 0.62 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.55 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.53 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.53 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CPA1 | P15085 | 2/20 | 0.47 |
| ▸ | CPB1 | P15086 | 1/20 | 0.47 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3440803 | 1.00 | CPA3 (0.62) | CPA3KEAP1CYSLTR2CYSLTR1NAALAD2 | |
| SCHEMBL18576990 | 0.90 | FFAR1 (0.61) | CPA3CYSLTR2CYSLTR1FFAR1 | |
| SCHEMBL28588548 | 0.89 | CPA3 (0.54) | CPA3KEAP1CYSLTR2CYSLTR1NAALAD2 | |
| SCHEMBL13235780 | 0.87 | ALDH1A1 (0.55) | CPA3SLC15A1NPC1RAB9ACYP1A2 | |
| SCHEMBL20208030 | 0.87 | ALDH1A1 (0.55) | CPA3SLC15A1NPC1RAB9ACYP1A2 | |
| SCHEMBL29016766 | 0.86 | HDAC1 (0.58) | LTA4HHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL29339199 | 0.86 | MAPT (0.56) | CPA3KEAP1NAALAD2FFAR1SLC15A1 | |
| SCHEMBL7400003 | 0.85 | CYSLTR2 (0.52) | CPA3CYSLTR2CYSLTR1NAALAD2FFAR1 | |
| SCHEMBL25633090 | 0.85 | FFAR1 (0.51) | CPA3CYSLTR2CYSLTR1FFAR1MAPK1 | |
| SCHEMBL28228765 | 0.85 | EPHX1 (0.47) | CPA3SLC15A1NPC1RAB9ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11685734-B2 | ATM kinase inhibitors and compositions and methods of use thereof | CHDI FOUNDATION, INC. (US) | 2023-06-27 | — | — | US | disclosed |
| US-20230173093-A1 | CHARGE VARIANT LINKERS | SEAGEN INC (US) | 2023-06-08 | — | — | US | disclosed |
| US-8138145-B2 | Hybrid oligomers, their preparation process and pharmaceutical compositions containing them | Centre National de la Recherche Scientifique (SNRS) (FR) | 2012-03-20 | — | — | US | disclosed |
| US-20100298206-A1 | HYBRID OLIGOMERS, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), I.B.M.C. (FR) | 2010-11-25 | — | — | US | disclosed |
| US-7691807-B2 | Hybrid oligomers, their preparation process and pharmaceutical compositions containing them | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2010-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298206-A1 | HYBRID OLIGOMERS, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | NOD2, NOD1, COG5 | CPA3 3506/4885KEAP1 353/4885CYSLTR2 2698/4885 |
| US-11685734-B2 | ATM kinase inhibitors and compositions and methods of use thereof | ATM, CHEK2, CHEK1 | CPA3 4597/4885KEAP1 718/4885CYSLTR2 4354/4885 |
| US-20230173093-A1 | CHARGE VARIANT LINKERS | SSB, UACA, CDA | CPA3 725/4885KEAP1 3559/4885CYSLTR2 852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.